{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:07:07Z","timestamp":1793995627681,"version":"4.8.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.112043","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T13:12:43Z","timestamp":1629119563000},"page":"112043","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids"],"prefix":"10.1016","volume":"142","author":[{"given":"Mohamed","family":"Elbadawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimika","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Ayame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Abugomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Shibutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shim-Mo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Hazama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Takenouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryouichi","family":"Tsunedomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Yamawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2021.112043_bib1","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"17","key":"10.1016\/j.biopha.2021.112043_bib2","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/molecules25173798","article-title":"The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one), inhibits cell proliferation and induces apoptosis in primary and metastatic human colon cancer cells","volume":"25","author":"Ismail","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2021.112043_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5935\/0101-2800.20130052","article-title":"Acute nephrotoxicity of cisplatin: molecular mechanisms","volume":"35","author":"Peres","year":"2013","journal-title":"J. Bras. Nefrol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112043_bib4","first-page":"292","article-title":"TAS-102 (Lonsurf) for the treatment of metastatic colorectal cancer. A concise review","volume":"15","author":"Zaniboni","year":"2016","journal-title":"Clin. Colorectal Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010197","article-title":"Colorectal carcinoma: a general overview and future perspectives in colorectal cancer","volume":"18","author":"Marmol","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2021.112043_bib6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1055\/s-0030-1249961","article-title":"Modulation of apoptosis by natural products for cancer therapy","volume":"76","author":"Fulda","year":"2010","journal-title":"Planta Med."},{"issue":"5","key":"10.1016\/j.biopha.2021.112043_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3906\/biy-2003-18","article-title":"Caffeic acid phenethyl ester induces apoptosis in colorectal cancer cells via inhibition of survivin","volume":"44","author":"Sari","year":"2020","journal-title":"Turk. J. Biol."},{"issue":"22","key":"10.1016\/j.biopha.2021.112043_bib8","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.3390\/molecules25225319","article-title":"Plant-derived natural products in cancer research: extraction, mechanism of action, and drug formulation","volume":"25","author":"Talib","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2021.112043_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/10826068.2019.1575859","article-title":"Extraction of curcuminoids from Curcuma longa: comparative study between batch extraction and novel three phase partitioning","volume":"49","author":"Patil","year":"2019","journal-title":"Prep. Biochem. Biotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112043_bib10","first-page":"588","article-title":"Curcuma as a functional food in the control of cancer and inflammation","volume":"14","author":"Schaffer","year":"2011","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"9","key":"10.1016\/j.biopha.2021.112043_bib11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/mnfr.201200838","article-title":"Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: identification of novel components of turmeric","volume":"57","author":"Aggarwal","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2021.112043_bib12","doi-asserted-by":"crossref","first-page":"01021","DOI":"10.3389\/fphar.2020.01021","article-title":"Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications","volume":"11","author":"Sharifi-Rad","year":"2020","journal-title":"Front. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2021.112043_bib13","first-page":"1343","article-title":"Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells","volume":"53","author":"Su","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2021.112043_bib14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2021.112043_bib15","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1007\/s11095-009-9955-6","article-title":"Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice","volume":"26","author":"Padhye","year":"2009","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/biof.1042","article-title":"Curcumin uptake and metabolism","volume":"39","author":"Metzler","year":"2013","journal-title":"Biofactors"},{"issue":"6","key":"10.1016\/j.biopha.2021.112043_bib17","first-page":"535","article-title":"Chemopreventive efficacy and pharmacokinetics of curcumin in the min\/+ mouse, a model of familial adenomatous polyposis","volume":"11","author":"Perkins","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6882-6-10","article-title":"Dose escalation of a curcuminoid formulation","volume":"6","author":"Lao","year":"2006","journal-title":"BMC Complement Alter. Med."},{"issue":"3","key":"10.1016\/j.biopha.2021.112043_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/187152012800228733","article-title":"Curcumin and its formulations: potential anti-cancer agents","volume":"12","author":"Ji","year":"2012","journal-title":"Anticancer Agents Med Chem."},{"issue":"10","key":"10.1016\/j.biopha.2021.112043_bib20","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1016\/j.biomaterials.2013.12.090","article-title":"Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment","volume":"35","author":"Naksuriya","year":"2014","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biopha.2021.112043_bib21","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/pharmaceutics11090442","article-title":"Molecular interactions for the curcumin-polymer complex with enhanced anti-inflammatory effects","volume":"11","author":"He","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/10717544.2017.1422298","article-title":"Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2021.112043_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.foodchem.2014.01.108","article-title":"Enhanced bioavailability and bioefficacy of an amorphous solid dispersion of curcumin","volume":"156","author":"Chuah","year":"2014","journal-title":"Food Chem."},{"issue":"6194","key":"10.1016\/j.biopha.2021.112043_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.biopha.2021.112043_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119823","article-title":"Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model","volume":"237","author":"Elbadawy","year":"2020","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib26","doi-asserted-by":"crossref","first-page":"9393","DOI":"10.1038\/s41598-020-66229-w","article-title":"Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture","volume":"10","author":"Abugomaa","year":"2020","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2021.112043_bib27","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.chembiol.2017.06.012","article-title":"Tumor organoids as a pre-clinical cancer model for drug discovery","volume":"24","author":"Weeber","year":"2017","journal-title":"Cell Chem. Biol."},{"issue":"S1","key":"10.1016\/j.biopha.2021.112043_bib28","first-page":"28","article-title":"Session 6: advances in anticancer therapy. Urine sample-derived cancer organoids enable tailor-made medicine of dog prostate cancer.","volume":"41","author":"Usui","year":"2018","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/23808993.2020.1715794","article-title":"Patient-derived organoid analysis of drug resistance in precision medicine: is there a value?","volume":"5","author":"Abugomaa","year":"2020","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/cells9010235","article-title":"Emerging roles of cancer stem cells in bladder cancer progression, tumorigenesis, and resistance to chemotherapy: a potential therapeutic target for bladder cancer","volume":"9","author":"Abugomaa","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.biopha.2021.112043_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060164","article-title":"Development of an experimental model for analyzing drug resistance in colorectal cancer","volume":"10","author":"Elbadawy","year":"2018","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.biopha.2021.112043_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040777","article-title":"Development of prostate cancer organoid culture models in basic medicine and translational research","volume":"12","author":"Elbadawy","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2021.112043_bib33","unstructured":"T. Nakao, Mikihiko Nakamura, M. Nishino., Polyphenol-containing solid composition; San Ei Gen FFI Inc., Assignee. Polyphenol-containing solid composition. U.S. Patent No. 10,709,672, 14 Jul. 2020."},{"issue":"4","key":"10.1016\/j.biopha.2021.112043_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041098","article-title":"Hedgehog signals mediate anti-cancer drug resistance in three-dimensional primary colorectal cancer organoid culture","volume":"19","author":"Usui","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112043_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7053872","article-title":"Establishment of a novel model for anticancer drug resistance in three-dimensional primary culture of tumor microenvironment","volume":"2016","author":"Usui","year":"2016","journal-title":"Stem Cells Int."},{"issue":"12","key":"10.1016\/j.biopha.2021.112043_bib36","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/cas.13418","article-title":"Establishment of a dog primary prostate cancer organoid using the urine cancer stem cells","volume":"108","author":"Usui","year":"2017","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.biopha.2021.112043_bib37","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1111\/cas.14118","article-title":"Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture","volume":"110","author":"Elbadawy","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2021.112043_bib38","first-page":"1","article-title":"Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism","author":"Elbadawy","year":"2021","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2021.112043_bib39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.mad.2012.05.004","article-title":"Curcumin induces permanent growth arrest of human colon cancer cells: link between senescence and autophagy","volume":"133","author":"Mosieniak","year":"2012","journal-title":"Mech. Ageing Dev."},{"issue":"6","key":"10.1016\/j.biopha.2021.112043_bib40","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4196\/kjpp.2010.14.6.391","article-title":"Curcumin induces downregulation of e2f4 expression and apoptotic cell death in HCT116 human colon cancer cells; involvement of reactive oxygen species","volume":"14","author":"Kim","year":"2010","journal-title":"Korean J. Physiol. Pharm."},{"key":"10.1016\/j.biopha.2021.112043_bib41","article-title":"Curcumin and colorectal cancer: an update and current perspective on this natural medicine","author":"Weng","year":"2020","journal-title":"Semin Cancer Biol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112043_bib42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/B:HIJO.0000032361.98815.bb","article-title":"Curcumin, a multi-functional chemopreventive agent, blocks growth of colon cancer cells by targeting beta-catenin-mediated transactivation and cell-cell adhesion pathways","volume":"35","author":"Narayan","year":"2004","journal-title":"J. Mol. Histol."},{"issue":"10","key":"10.1016\/j.biopha.2021.112043_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102454","article-title":"Mechanism of apoptosis induced by curcumin in colorectal cancer","volume":"20","author":"Ismail","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.112043_bib44","doi-asserted-by":"crossref","unstructured":"Y. Sunagawa, Y. Miyazaki, M. Funamoto, K. Shimizu, S. Shimizu, S. Nurmila, Y. Katanasaka, M. Ito, T. Ogawa, H. Ozawa-Umeta, K. Hasegawa, T. Morimoto, A Novel Amorphous Curcumin Preparation Improved Oral Absorption Efficiency in Healthy Volunteers: A Single-Dose, Double-Blind, Two-Way Crossover Study, PREPRINT (Version 1) available at Research Square (2020).","DOI":"10.21203\/rs.3.rs-104381\/v1"},{"issue":"4B","key":"10.1016\/j.biopha.2021.112043_bib45","first-page":"2895","article-title":"Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions","volume":"21","author":"Cheng","year":"2001","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib46","doi-asserted-by":"crossref","first-page":"13869","DOI":"10.1038\/s41598-018-32267-8","article-title":"A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer","volume":"8","author":"Ravindranathan","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2021.112043_bib47","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3390\/ijms21072364","article-title":"Curcumin and colorectal cancer: from basic to clinical evidences","volume":"21","author":"Pricci","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2021.112043_bib48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1158\/1940-6207.CAPR-13-0387","article-title":"Curcumin suppresses proliferation of colon cancer cells by targeting CDK2","volume":"7","author":"Lim","year":"2014","journal-title":"Cancer Prev. Res. (Philos. )"},{"issue":"7001","key":"10.1016\/j.biopha.2021.112043_bib49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nature02820","article-title":"Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control","volume":"430","author":"Hernando","year":"2004","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-8722-3-8","article-title":"From basic research to clinical development of MEK1\/2 inhibitors for cancer therapy","volume":"3","author":"Fremin","year":"2010","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.biopha.2021.112043_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092340","article-title":"Emerging roles of C-Myc in cancer stem cell-related signaling and resistance to cancer chemotherapy: a potential therapeutic target against colorectal cancer","volume":"20","author":"Elbadawy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"52","key":"10.1016\/j.biopha.2021.112043_bib52","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1038\/sj.onc.1204997","article-title":"Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines","volume":"20","author":"Mukhopadhyay","year":"2001","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.biopha.2021.112043_bib53","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3892\/etm.2015.2749","article-title":"Biological and therapeutic activities, and anticancer properties of curcumin","volume":"10","author":"Perrone","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"11","key":"10.1016\/j.biopha.2021.112043_bib54","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41416-018-0118-6","article-title":"Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic?","volume":"118","author":"Morgan","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"36","key":"10.1016\/j.biopha.2021.112043_bib55","doi-asserted-by":"crossref","first-page":"13427","DOI":"10.1073\/pnas.0805706105","article-title":"Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity","volume":"105","author":"Vermeulen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2021.112043_bib56","first-page":"20","article-title":"Clinical utility of curcumin extract","volume":"19","author":"Asher","year":"2013","journal-title":"Alter. Ther. Health Med."},{"issue":"4","key":"10.1016\/j.biopha.2021.112043_bib57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","article-title":"Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4","volume":"1","author":"Todaro","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.biopha.2021.112043_bib58","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1053\/j.gastro.2009.12.063","article-title":"Colon cancer stem cells: promise of targeted therapy","volume":"138","author":"Todaro","year":"2010","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biopha.2021.112043_bib59","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ijc.23097","article-title":"Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R","volume":"122","author":"Patel","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2021.112043_bib60","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1593\/tlo.09193","article-title":"Elimination of colon cancer stem-like cells by the combination of curcumin and FOLFOX","volume":"2","author":"Yu","year":"2009","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biopha.2021.112043_bib61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-2187-6-7","article-title":"Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells","volume":"6","author":"Nautiyal","year":"2011","journal-title":"J. Mol. Signal"},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1208\/s12249-011-9732-9","article-title":"Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion","volume":"13","author":"Wan","year":"2012","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.biopha.2021.112043_bib63","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/1678-457x.02817","article-title":"Effects of curcumin on growth of human cervical cancer xenograft in nude mice and underlying mechanism","volume":"38","author":"Liu","year":"2018","journal-title":"Food Sci. Technol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112043_bib64","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1158\/1078-0432.CCR-07-4722","article-title":"Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products","volume":"14","author":"Kunnumakkara","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.biopha.2021.112043_bib65","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4161\/cbt.12.9.17671","article-title":"C086, a novel analog of curcumin, induces growth inhibition and down-regulation of NFkappaB in colon cancer cells and xenograft tumors","volume":"12","author":"Chen","year":"2011","journal-title":"Cancer Biol. Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100826X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222100826X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:36:13Z","timestamp":1760099773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222100826X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":65,"alternative-id":["S075333222100826X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112043","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112043"}}